BookFrontier
The Billion-dollar Molecule by Barry Werth

Book

The Billion-dollar Molecule

The Quest for the Perfect Drug

Barry Werth

Simon & Schuster · Print & ebook · March 1, 1995

Reading lane: Pharma & Biotech Industry

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.

At a Glance

Why This Clicks

Science Meets Finance

Drug discovery meets startup ambition in a close-up of science, competition, and finance.

Come here for

  • The uneasy partnership between lab work and Wall Street
  • A view into pharmaceutical research as both science and business

Expect

  • Competitive scientists and investor dealmaking
  • Drug research alongside the push to take a company public

Book Details

Authors
Barry Werth
Publisher
Simon & Schuster
Published
March 1, 1995
Format
Print & ebook
Theme
Pharma & Biotech Industry · Leukemia & Lymphoma
Reading lane
Pharma & Biotech Industry

Affinity

Publisher Categories

  • Business & Economics

  • Pharma & Biotech Industry

  • Molecular Modeling

About This Book

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start...

Read full description

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.

Similar Books